Inotuzumab Ozogamicin Combined with Low-Intensity,with or without Blinatumomab vs. Intensive Therapy for Older Patients with Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: A Propensity Score Analysis
1. Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States;2. Chao Family Comprehensive Cancer Center, University of California Irvine, Orange, California, United States